Lawsuits Challenge 340B Drug Pricing Program: E...

By Rene Pretorius

November 22, 2024

Eli Lilly and Johnson & Johnson (J&J) have filed lawsuits against the Health Resources and Services Administration (HRSA) regarding their proposed rebate models for the
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
Strategies to Control Rising Health Insurance Premiums in Singapore
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
The Trump Drug Policy Change: A Reverse Course
Thailand’s Healthcare System and the Role of HTA: A Model of Universal ...
Addressing Financial Hardship in Healthcare: A Focus on Older Informal Worker...
Caring for an Ageing US Population: Challenges and Innovations
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...